Gender	Female
E-mail	renee.arnold@mssm.edu
Education and Training	PharmD., University of Southern California
	B.S., University of Maryland
	Residency, University of California at San Francisco

Dr. Arnold's clinical interests include:
Pediatric and adult asthma
Atopic Dermatitis
Human Papillomavirus Vaccine
Heparin-induced thrombocytopenia
Renal Transplant
Real-world application of pharmacoeconomic principles
Decision analysis
Cost-effectiveness analysis
Interactive software in medical decision-making
Outcomes research in asthma, dermatology, cardiovascular medicine, HPV vaccines, pediatrics

Languages:
English
French

Education and Training	PharmD., University of Southern California
	B.S., University of Maryland
	Residency, University of California at San Francisco

Arnold R. Introduction to Pharmacoeconomics...from theory to practice (in press). Boca Raton, Taylor and Francis Group, LLC;.

Arnold RG, Kuan RK. Quality of life and costs in atopic dermatitis. In: Preedy VR, Watson RR, editors. Handbook of Disease Burdens and Quality of Life Measures (2008). Heidelberg, Springer;.

Marcus P, Arnold RG, Ekins S, Et Al. . A Retrospective Randomized Study of Asthma Control in the US: Results of the CHARIOT Study. Current Medical Research and Opinion 2008; 24: 3443-3452.

Cheng JM, Arnold RG. Pharmacoeconomic Review of Medical Management of Persistent Asthma. Allergy and Asthma Proceedings 2008 March-April; 29(2).

Arnold RG. Cost-Effectiveness Analysis: Should It Be Required for Drug Registration and Beyond?. Drug Discov Today 2007; 12/21-22: 960-965.

Arnold RG, Donnelly A, Altieri L, Wong KS, Sung J. Assessment of outcomes and parental impact on quality of life endpoints in the management of atopic dermatitis (ATOPIQUE). Managed Care Interface 2007; 20: 18-23.

Arnold R. Use of interactive software in medical decision making. In: Ekins S, editor. Computer Applications in Pharmaceutical Research and Development (2006). Hoboken, John Wiley & Sons, Inc.;.

Arnold RG, Kim R, Tang B. The cost-effectiveness of argatroban treatment in heparin-induced thrombocytopenia: the effect of early versus delayed treatment. Cardiol Rev 2006; 14: 7-13.